Market Place
Sourcing Support
All News #Library
Others
Tectonic Therapeutic Appoints Jessica Chutter To Board
23 Apr 2026 //
FIRSTWORD PHARMA
Tectonic Therapeutics Names Dr. François Nader as Board Chair
23 Feb 2026 //
GLOBENEWSWIRE
Tectonic Therapeutic Q1 Financial Results & Business Highlight
08 May 2025 //
GLOBENEWSWIRE
Tectonic Reports Positive TX45 Ph 1b In Pulmonary Hypertension
30 Jan 2025 //
GLOBENEWSWIRE
Tectonic Closes AVROBIO Merger And Raises $130.7M In Concurrent Placement
20 Jun 2024 //
BUSINESSWIRE
Tectonic Therapeutic Appoints Daniel Lochner as Chief Financial Officer
03 Jun 2024 //
BUSINESSWIRE
Tectonic initiates Phase 1B for TX45 in Group 2 PH with HFpEF
26 Mar 2024 //
BUSINESSWIRE
Tectonic Therapeutic Announces Participation at Investor Conferences in March
27 Feb 2024 //
BUSINESSWIRE
Tectonic Announces Start of First Clinical Program for GPCR-Targeted Biologic
28 Nov 2023 //
BUSINESSWIRE
Tectonic Therapeutic Strengthens Leadership Team
19 Jul 2022 //
BUSINESSWIRE
Tectonic snags Regeneron`s Dupixent program leader as CMO
22 Jul 2021 //
FIERCEBIOTECH
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.